1995年《私人证券诉讼改革法案》规定的“安全港”声明:
在此新闻稿中所作的任何陈述包含的信息不是历史的;这些陈述是前瞻性的，表达了管理层的信念和期望。此类陈述基于当前预期，涉及许多已知和未知的风险和不确定性，这些风险和不确定性可能导致公司未来的结果、业绩或成就与此类前瞻性陈述所表达或暗示的结果、业绩或成就显著不同。这些风险和不确定性包括但不限于:收入和营业收入的波动;公司及时成功开发和商业化医药产品的能力;与重要客户的业务减少或损失;公司总收入的很大一部分来自有限数量产品的销售;公司客户基础整合的影响;竞争的影响;公司维持盈利能力和正现金流的能力; any delays or unanticipated expenses in connection with the operation of the Company's manufacturing facilities; the effect of foreign economic, political, legal, and other risks on the Company's operations abroad; the uncertainty of patent litigation and other legal proceedings; the increased government scrutiny on the Company's agreements with brand pharmaceutical companies; product development risks and the difficulty of predicting FDA filings and approvals; consumer acceptance and demand for new pharmaceutical products; the impact of market perceptions of the Company and the safety and quality of the Company's products; the Company's determinations to discontinue the manufacture and distribution of certain products; the Company's ability to achieve returns on its investments in research and development activities; changes to FDA approval requirements; the Company's ability to successfully conduct clinical trials; the Company's reliance on third parties to conduct clinical trials and testing; the Company's lack of a license partner for commercialization of NUMIENT™(IPX066)的外部美国；第三方非法经销、销售假冒、被盗产品的影响;原材料的可用性和公司供应链中断的影响;公司关于退货、免税额和退款的政策;在公司产品中使用受控物质;当前经济状况对公司行业、业务、经营成果和财务状况的影响;因第三方违约或其他事件导致的公司信息技术系统和网络基础设施中断或故障;公司对联盟和合作协议的依赖;公司对专有技术许可的依赖;公司对某些员工的依赖; the Company's ability to comply with legal and regulatory requirements governing the healthcare industry; the regulatory environment; the effect of certain provisions in the Company's government contracts; the Company's ability to protect its intellectual property; exposure to product liability claims; risks relating to goodwill and intangibles; changes in tax regulations; the Company's ability to manage growth, including through potential acquisitions and investments; the risks related to the Company's acquisitions of or investments in technologies, products or businesses; the restrictions imposed by the Company's credit facility and indenture; the Company's level of indebtedness and liabilities and the potential impact on cash flow available for operations; uncertainties involved in the preparation of the Company's financial statements; the Company's ability to maintain an effective system of internal control over financial reporting; the effect of terrorist attacks on the Company's business; the location of the Company's manufacturing and research and development facilities near earthquake fault lines; expansion of social media platforms and other risks described in the Company's periodic reports filed with the Securities and Exchange Commission. Forward-looking statements speak only as to the date on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.